YDR061W Antibody

What is YDR061W and what is its significance in yeast biology?

YDR061W is a protein found in Saccharomyces cerevisiae (baker's yeast), specifically in the reference strain ATCC 204508/S288c. This protein has been identified as one of the ABC (ATP-binding cassette) proteins in yeast, though notably, it is not closely homologous to any mammalian proteins in this family . The protein is encoded by the YDR061W gene and has the UniProt accession number Q12298 .

From a biological perspective, YDR061W belongs to a class of proteins that typically function as transporters, though its specific substrate specificity and biological role remain less characterized compared to other yeast ABC transporters such as Ycf1p. The study of YDR061W can provide insights into the evolution and diversification of ABC transporters in fungi compared to other eukaryotes, particularly since it lacks close mammalian homologs.

What are the biochemical specifications of commercially available YDR061W antibodies?

The YDR061W antibody (Product Code: CSB-PA623603XA01SVG) is a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae YDR061W protein . The antibody is:

• Type: Polyclonal

• Host: Rabbit

• Immunogen: Recombinant S. cerevisiae (strain ATCC 204508/S288c) YDR061W protein

• Reactivity: Specific to S. cerevisiae (strain ATCC 204508/S288c)

• Form: Liquid

• Conjugation: Non-conjugated

• Purification Method: Antigen Affinity Purified

• Isotype: IgG

• Storage Buffer: Contains 0.03% Proclin 300 (preservative), 50% Glycerol, 0.01M PBS (pH 7.4)

This antibody has been validated for ELISA and Western Blot applications, making it suitable for detecting and studying YDR061W protein expression in yeast samples .

How does YDR061W compare structurally and functionally to other yeast ABC transporters?

While the search results don't provide explicit structural comparison data for YDR061W versus other ABC transporters, we can infer its relationship from contextual information. In the ABC transporter family, YDR061W is mentioned as distinct from the well-characterized transporters like Ycf1p .

Most yeast ABC transporters share a common architecture with:

• Nucleotide-binding domains (NBDs) that bind and hydrolyze ATP

• Membrane-spanning domains (MSDs) that form the translocation pathway

• In some cases, additional domains like N-terminal extensions (NTEs)

Unlike Ycf1p and other MRP family transporters that have been extensively studied for their roles in detoxification and metabolite transport, YDR061W's precise transport capabilities and substrates remain less defined. This suggests opportunities for researchers to characterize this protein's role in yeast cellular processes through targeted experiments utilizing the YDR061W antibody.

How should researchers design Western blot protocols for optimal YDR061W detection?

When designing Western blot protocols for YDR061W detection, researchers should consider the following methodology:

Sample Preparation:

• Harvest yeast cells at mid-log phase to ensure consistent protein expression

• Lyse cells using glass bead disruption in a buffer containing protease inhibitors

• Clear lysates by centrifugation (14,000 × g, 10 min, 4°C)

• Quantify protein concentration using Bradford or BCA assay

SDS-PAGE and Transfer:

• Load 20-50 μg of total protein per lane

• Separate proteins using 10-12% polyacrylamide gels

• Transfer to PVDF membrane (recommended over nitrocellulose for yeast proteins)

• Verify transfer efficiency with reversible staining (Ponceau S)

Immunoblotting:

• Block membrane with 5% non-fat dry milk in TBST for 1 hour at room temperature

• Incubate with YDR061W antibody at 1:500-1:2000 dilution (start with manufacturer's recommendation)

• Incubate overnight at 4°C with gentle agitation

• Wash 4× with TBST, 5 minutes each

• Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000-1:10000)

• Wash 4× with TBST, 5 minutes each

• Develop using ECL substrate and image

Critical Controls:

• Positive control: Extract from wild-type S. cerevisiae (S288c strain)

• Negative control: Extract from YDR061W deletion strain

• Loading control: Anti-PGK1 or anti-tubulin antibody

The expected molecular weight of YDR061W should be verified against the UniProt entry (Q12298) to ensure specific detection.

What are the recommended protocols for using YDR061W antibody in immunoprecipitation studies?

While the search results don't specifically mention immunoprecipitation (IP) protocols for YDR061W antibody, the following methodology is recommended based on similar polyclonal antibodies against yeast proteins:

Pre-clearing Step:

• Prepare yeast lysate in IP buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, protease inhibitors)

• Add 50 μl Protein A/G beads per 1 ml lysate

• Rotate for 1 hour at 4°C

• Remove beads by centrifugation (1000 × g, 5 min)

Immunoprecipitation:

• Add YDR061W antibody to pre-cleared lysate (2-5 μg antibody per 1 mg protein)

• Incubate overnight at 4°C with gentle rotation

• Add 50 μl Protein A/G beads

• Rotate for 3 hours at 4°C

• Collect beads by centrifugation (1000 × g, 5 min)

• Wash 4× with IP buffer

• Elute proteins by boiling in SDS sample buffer or with glycine elution (0.1 M, pH 2.5)

Analysis:

• Analyze immunoprecipitated proteins by Western blot

• For protein interaction studies, consider mass spectrometry analysis of co-precipitated proteins

When validating a new IP protocol, researchers should verify the efficiency of pull-down using Western blot analysis of input, unbound, and eluted fractions.

How can ELISA be optimized for YDR061W detection in yeast samples?

For optimizing ELISA detection of YDR061W in yeast samples, a sandwich ELISA approach is recommended :

Plate Preparation:

• Coat high-binding 96-well plates with capture antibody (1-10 μg/ml in coating buffer)

• Incubate overnight at 4°C

• Wash 3× with PBST

• Block with 1% BSA in PBS for 1 hour at room temperature

Sample Processing:

• Prepare yeast lysates in non-denaturing lysis buffer

• Clarify by centrifugation (14,000 × g, 15 min)

• Dilute samples in sample diluent (PBS with 0.1% BSA)

• Add samples to wells and incubate for 2 hours at room temperature

Detection:

• Wash 5× with PBST

• Add diluted YDR061W antibody (1:500-1:2000) and incubate for 2 hours

• Wash 5× with PBST

• Add HRP-conjugated anti-rabbit secondary antibody and incubate for 1 hour

• Wash 5× with PBST

• Add TMB substrate and monitor color development

• Stop reaction with 2N H₂SO₄ and read absorbance at 450 nm

Standard Curve:

• If purified recombinant YDR061W is available, prepare a standard curve (0-1000 ng/ml)

• Include standards on each plate for quantification

Optimization Considerations:

• Test multiple antibody concentrations in a checkerboard titration

• Optimize incubation times and temperatures

• Evaluate different blocking reagents (BSA vs. casein vs. commercial blockers)

What are the critical storage parameters for maintaining YDR061W antibody activity?

The YDR061W antibody requires specific storage conditions to maintain its activity and specificity over time:

Storage Temperature:

• Upon receipt, store at -20°C or -80°C

• For working aliquots, -20°C is generally sufficient

Aliquoting Recommendations:

• Divide the stock antibody into small single-use aliquots (10-20 μl)

• Use sterile microcentrifuge tubes

• Avoid repeated freeze-thaw cycles, as explicitly warned in the product documentation

Buffer Stability:

• The antibody is supplied in a stabilizing buffer containing:

  • 50% Glycerol (cryoprotectant)

  • 0.01M PBS, pH 7.4 (physiological buffer)

  • 0.03% Proclin 300 (preservative)

• This formulation helps maintain antibody stability during storage

Working Solution Handling:

• When preparing diluted working solutions, use sterile buffers

• Working solutions can be stored at 4°C for up to one week

• For longer storage, return to -20°C

Shipping and Temporary Storage:

• If temporary storage is required during experiments, keep the antibody on ice

• Avoid prolonged exposure to room temperature

Proper storage is particularly important for this antibody since it is described as "made-to-order" with a 14-16 week lead time , making replacement potentially time-consuming for research projects.

What validation experiments should be performed before using YDR061W antibody in critical experiments?

Before using the YDR061W antibody in critical experiments, researchers should conduct several validation experiments to ensure specificity and reliability:

Specificity Validation:

• Western Blot with Positive and Negative Controls

  • Compare wild-type S. cerevisiae (S288c strain) with YDR061W knockout strain

  • Verify single band at expected molecular weight

• Peptide Competition Assay

  • Pre-incubate antibody with excess immunizing peptide/protein

  • Run parallel Western blots with blocked and unblocked antibody

  • Specific signal should disappear in the blocked antibody lane

• Immunostaining Control Experiments

  • Perform parallel staining with pre-immune serum

  • Include secondary-only controls to assess background

Performance Validation:

• Antibody Titration

  • Test serial dilutions (1:250 to 1:5000) to identify optimal concentration

  • Determine minimum antibody concentration that maintains signal-to-noise ratio

• Cross-Reactivity Assessment

  • Test against lysates from related yeast species

  • Confirm specificity to S. cerevisiae (strain ATCC 204508/S288c)

• Reproducibility Test

  • Perform replicate experiments under identical conditions

  • Verify consistent detection across different batches of cell lysate

Documentation Requirements:

• Record lot number and all validation data

• Document optimal conditions determined during validation

• Create a standardized protocol based on validation results

This systematic validation approach ensures that experimental results with the YDR061W antibody will be reliable and reproducible across different studies.

What are the compatibility considerations for dual-labeling experiments with YDR061W antibody?

When planning dual-labeling experiments that include YDR061W antibody, researchers must consider several factors to ensure successful multiplexing:

Host Species Considerations:

• YDR061W antibody is raised in rabbit

• For dual labeling, select secondary antibodies with:

  • Different host species (e.g., mouse, goat)

  • Non-cross-reactive secondaries

Fluorophore Selection for Immunofluorescence:

• Choose fluorophores with minimal spectral overlap

• Recommended combinations:

  • YDR061W (rabbit) + Alexa Fluor 488

  • Second target (mouse) + Alexa Fluor 594/647

Sequential vs. Simultaneous Staining:

• For membrane proteins, sequential staining often yields better results

• For different cellular compartments, simultaneous staining may work well

Western Blot Considerations:

• If targets have similar molecular weights:

  • Strip and reprobe membrane sequentially

  • Use differently colored detection systems (e.g., red and green fluorescent secondaries)

• If targets have different molecular weights:

  • Cut membrane horizontally and probe sections separately

Control Experiments for Dual Labeling:

• Single primary antibody controls with both secondary antibodies

• Secondary-only controls

• Absorption controls with specific blocking peptides

Table 1: Recommended Secondary Antibody Combinations for Dual Labeling with YDR061W Antibody

Following these considerations will help ensure clean, specific labeling when using YDR061W antibody in multiplexed experiments.

How can YDR061W antibody be utilized to study potential interactions with other ABC transporters in yeast?

The YDR061W antibody can be strategically employed to investigate potential interactions with other ABC transporters through several advanced techniques:

Co-Immunoprecipitation (Co-IP) Studies:

• Use YDR061W antibody as the primary precipitating antibody

• Process lysates under native conditions to preserve protein-protein interactions

• Analyze precipitates for the presence of other ABC transporters using specific antibodies

• Perform reciprocal Co-IPs with antibodies against other ABC transporters

• Validate interactions with controls including IgG-only precipitations

Proximity Ligation Assay (PLA):

• Co-stain fixed yeast cells with YDR061W antibody and antibodies against other ABC transporters

• Apply species-specific PLA probes

• Perform rolling circle amplification if proteins are in close proximity (<40nm)

• Visualize interaction signals by fluorescence microscopy

• Quantify interaction frequency in different cellular compartments

Bimolecular Fluorescence Complementation (BiFC):

• Create fusion constructs of YDR061W and potential interacting partners

• Express in yeast and visualize reconstituted fluorescence

• Use the antibody to verify expression levels in parallel experiments

Relevance to ABC Transporter Biology:
The yeast genome encodes multiple ABC transporters with diverse functions. While specific YDR061W interactions aren't detailed in the search results, similar proteins like Ycf1p have been shown to interact with other cellular components . As noted in research on Ycf1p, "NBD1 may functionally interact with NBD2, MSD1, and MSD2 for proper Ycf1p function" , suggesting that such domain interactions could be studied in YDR061W as well.

Investigating these interactions could help determine whether YDR061W participates in larger complexes or networks involving other transporters, potentially providing insights into functional redundancy or specialization among yeast ABC transporters.

What approaches can be used to investigate the subcellular localization of YDR061W in different yeast growth conditions?

To investigate YDR061W subcellular localization across different growth conditions, researchers can employ several complementary approaches using the YDR061W antibody:

Immunofluorescence Microscopy:

• Fix yeast cells grown under different conditions (carbon sources, stress, etc.)

• Permeabilize cell walls (enzymatic digestion with zymolyase)

• Stain with YDR061W antibody and fluorescently-labeled secondary antibody

• Co-stain with organelle markers (e.g., DAPI for nucleus, MitoTracker for mitochondria)

• Analyze using confocal microscopy for precise localization

Subcellular Fractionation and Western Blotting:

• Fractionate yeast cells into distinct subcellular compartments:

  • Cytosol

  • Membrane fractions (ER, Golgi, plasma membrane, vacuole)

  • Nucleus

  • Mitochondria

• Confirm fraction purity with marker proteins

• Analyze each fraction by Western blot with YDR061W antibody

• Quantify relative distribution across compartments

Protease Protection Assays:

• Isolate membrane fractions containing YDR061W

• Treat with proteases with/without membrane permeabilization

• Analyze protected fragments by Western blot

• Determine membrane topology of YDR061W

Yeast GFP Collection Validation:

• Compare antibody-based localization with GFP-tagged YDR061W

• Verify that tagging hasn't altered localization

• Use antibody to confirm expression levels match untagged protein

Experimental Conditions to Test:

• Different carbon sources (glucose, galactose, glycerol)

• Nitrogen limitation

• Osmotic stress

• Heavy metal exposure (given the role of some ABC transporters in metal detoxification)

• Different growth phases (log, stationary)

This multi-faceted approach would allow researchers to create a comprehensive map of YDR061W localization under various physiological conditions, potentially revealing condition-specific relocalization that might indicate specialized functions.

How might YDR061W function be studied through integration of antibody-based detection with genetic knockout approaches?

The integration of antibody-based detection with genetic manipulation offers powerful approaches to elucidate YDR061W function:

Creation and Validation of Knockout Strains:

• Generate YDR061W deletion strains using homologous recombination

• Confirm deletion using PCR and Western blot with YDR061W antibody

• Assess growth phenotypes under various conditions

• Compare with wild-type strains using standardized growth assays

Phenotypic Characterization:

• Perform comprehensive phenotypic analysis of knockout strains:

  • Growth rates in different media

  • Stress tolerance (oxidative, osmotic, temperature)

  • Metal sensitivity/resistance

  • Metabolite profiling

• Use YDR061W antibody in parallel experiments with wild-type to correlate expression levels with phenotypes

Complementation Studies:

• Reintroduce YDR061W under native or inducible promoters

• Use antibody to verify expression levels

• Determine if wild-type phenotype is restored

• Test mutant versions of YDR061W for structure-function analysis

Synthetic Genetic Interactions:

• Cross YDR061W deletion with other ABC transporter mutants

• Screen for synthetic phenotypes (lethality, growth defects)

• Use antibody to verify expression of remaining transporters

• Map genetic interaction network

Substrate Identification Approaches:

• Compare metabolite profiles between wild-type and knockout strains

• Use antibody to immunoprecipitate YDR061W and identify bound molecules

• Perform in vitro transport assays with reconstituted protein

Similar approaches have been productive for other yeast ABC transporters. For example, with Ycf1p, researchers have identified its role in transporting glutathione conjugates and various xenobiotics through combined genetic and biochemical approaches . The search results mention that "the red ade2 assay has been used experimentally as a sensitive in vivo assay for the function of Ycf1p and/or its functional interactors" , suggesting similar phenotypic assays could be developed for YDR061W.

What are common technical issues when working with YDR061W antibody and how can they be resolved?

Researchers working with YDR061W antibody may encounter several technical challenges. Below are common issues and their solutions:

High Background in Western Blots:

• Problem: Non-specific binding causing excessive background

• Solutions:

  • Increase blocking time (overnight at 4°C)

  • Use alternative blocking agents (5% BSA instead of milk)

  • Add 0.1-0.5% Tween-20 to antibody dilution buffer

  • Decrease primary antibody concentration (try 1:2000-1:5000)

  • Increase washing steps (6 x 10 minutes instead of 3 x 5 minutes)

Weak or No Signal:

• Problem: Insufficient antigen detection

• Solutions:

  • Increase protein loading (50-100 μg total protein)

  • Increase antibody concentration (try 1:250-1:500)

  • Extend primary antibody incubation (overnight at 4°C)

  • Use enhanced chemiluminescence substrate with higher sensitivity

  • Check if protein extraction method preserves YDR061W (try different lysis buffers)

Multiple Bands in Western Blot:

• Problem: Potential degradation or non-specific binding

• Solutions:

  • Add fresh protease inhibitors to lysis buffer

  • Prepare samples immediately before loading

  • Reduce sample heating time (2 minutes at 95°C)

  • Perform peptide competition assay to identify specific bands

  • Test different concentrations of reducing agent

Inconsistent Results Between Experiments:

• Problem: Variation between experimental runs

• Solutions:

  • Standardize lysate preparation protocol

  • Use the same antibody lot number when possible

  • Include positive control in every experiment

  • Prepare larger batches of working dilutions

  • Document exact conditions for each experiment

Table 2: Troubleshooting Matrix for YDR061W Antibody Applications

Implementing these troubleshooting approaches will help researchers obtain reliable and reproducible results when working with YDR061W antibody.

How should researchers interpret and reconcile conflicting results between different antibody-based detection methods?

When faced with conflicting results between different antibody-based detection methods for YDR061W, researchers should follow a systematic approach to interpretation and reconciliation:

Understanding Methodological Differences:

• Recognize inherent differences between techniques:

  • Western blotting detects denatured proteins, potentially exposing hidden epitopes

  • ELISA may detect native conformations depending on the protocol

  • Immunofluorescence reveals spatial information but may have sensitivity limitations

  • Immunoprecipitation depends on epitope accessibility in solution

• Consider technical parameters affecting each method:

  • Detergent concentrations in buffers

  • Fixation methods for microscopy

  • Protein concentration and purity

  • Antibody dilutions and incubation conditions

Systematic Reconciliation Approach:

• Validate antibody performance in each assay independently:

  • Use known positive and negative controls

  • Titrate antibody concentrations for each method

  • Document assay-specific optimal conditions

• Perform complementary experiments:

  • If Western blot shows a band but immunofluorescence is negative:

    • Check subcellular fractionation to confirm protein location

    • Verify fixation methods aren't destroying epitopes

  • If ELISA is positive but Western blot is negative:

    • Test different protein extraction methods

    • Consider native vs. denaturing conditions

• Evaluate biological context:

  • Protein expression levels may vary with growth conditions

  • Post-translational modifications might affect epitope recognition

  • Protein-protein interactions could mask antibody binding sites

Data Integration Framework:

• Apply a weighted evaluation system:

  • Assign higher confidence to results with multiple controls

  • Consider the limitations of each technique

  • Evaluate whether results answer the specific research question

• Design follow-up experiments to resolve discrepancies:

  • Use alternative antibodies targeting different epitopes

  • Employ non-antibody methods (mass spectrometry, genetic tagging)

  • Modify protocols to more closely mimic conditions where positive results were obtained

This systematic approach acknowledges that different detection methods reveal different aspects of protein biology, and apparent conflicts often represent complementary rather than contradictory information about YDR061W.

What statistical approaches should be used when analyzing quantitative data from YDR061W antibody experiments?

Experimental Design Considerations:

• Power analysis:

  • Determine appropriate sample size before experiments

  • For Western blot quantification, minimum n=3 biological replicates

  • For immunofluorescence quantification, analyze >100 cells per condition

• Control inclusion:

  • Internal loading controls for normalization (housekeeping proteins)

  • Positive and negative controls for antibody specificity

  • Vehicle controls for treatment studies

Data Preprocessing:

• Normalization methods:

  • For Western blots: normalize to loading controls (tubulin, actin, PGK1)

  • For immunofluorescence: correct for background fluorescence

  • For ELISA: normalize to standard curve

• Outlier identification:

  • Apply Grubbs' test or Dixon's Q-test

  • Document any excluded data points and justification

Statistical Analysis Framework:

• For comparing two conditions:

  • Test for normality (Shapiro-Wilk test)

  • For normally distributed data: Student's t-test

  • For non-normal data: Mann-Whitney U test

• For multiple conditions:

  • One-way ANOVA followed by appropriate post-hoc test (Tukey's or Dunnett's)

  • For non-parametric data: Kruskal-Wallis with Dunn's post-hoc test

• For time-course or dose-response:

  • Two-way ANOVA with repeated measures

  • Consider area under curve (AUC) analysis

Advanced Statistical Approaches:

• Correlation analysis:

  • When comparing YDR061W levels with phenotypic data

  • Pearson (parametric) or Spearman (non-parametric) correlation

• Regression analysis:

  • For establishing relationships between YDR061W levels and experimental variables

  • Consider multiple regression for complex datasets

• Image analysis for localization studies:

  • Colocalization statistics (Pearson's coefficient, Manders' overlap)

  • Object-based colocalization for discrete structures

Reporting Standards:

Following these statistical approaches will ensure robust, reproducible, and meaningful interpretation of quantitative data generated using the YDR061W antibody across various experimental platforms.

How might YDR061W antibody be incorporated into systems biology approaches to understand yeast ABC transporter networks?

YDR061W antibody can serve as a valuable tool in systems biology approaches that aim to comprehensively understand the interrelated functions of yeast ABC transporters:

Network Mapping Applications:

• Protein-Protein Interaction Networks:

  • Use YDR061W antibody for immunoprecipitation coupled with mass spectrometry

  • Identify direct and indirect interactors under different conditions

  • Map YDR061W into existing ABC transporter interaction networks

• Co-expression Analysis:

  • Quantify YDR061W expression alongside other transporters using antibody arrays

  • Correlate expression patterns across growth conditions

  • Identify coordinately regulated transport systems

• Multi-omics Integration:

  • Combine antibody-based proteomics with:

    • Transcriptomics data for expression regulation

    • Metabolomics for substrate identification

    • Phenomics for functional relevance

Functional Redundancy Assessment:

• Compensatory Expression Analysis:

  • Monitor expression changes of YDR061W in strains with other ABC transporters deleted

  • Use the antibody to quantify upregulation that might indicate functional backup

  • Compare with studies of Ycf1p, where "for nearly all substrates tested to date, Ycf1p exhibits overlapping substrate specificity with its closest relative, Bpt1p"

• Synthetic Genetic Array Integration:

  • Correlate genetic interaction data with protein expression changes

  • Identify condition-specific functions through expression-phenotype correlations

Regulatory Network Investigation:

• Transcription Factor Studies:

  • Combine ChIP studies of transcription factors with antibody detection of YDR061W

  • Map regulatory connections between stress response and transporter expression

  • Create integrated regulatory models

• Post-translational Modification Mapping:

  • Use modified antibody approaches to detect phosphorylated or ubiquitinated forms

  • Construct signaling networks regulating YDR061W activity

Similar systems approaches have been applied to other ABC transporters in yeast. For instance, research on Ycf1p mentioned in the search results has revealed connections to broader cellular processes such as metabolic quality control , suggesting YDR061W might similarly be integrated into larger cellular systems.

What methodological adaptations would be needed to use YDR061W antibody in high-throughput screening approaches?

Adapting YDR061W antibody for high-throughput screening (HTS) requires specific methodological modifications to maintain reliability while increasing throughput:

Assay Miniaturization:

• Microplate ELISA Optimization:

  • Convert standard ELISA to 384- or 1536-well format

  • Reduce volumes (5-10 μl per well)

  • Optimize antibody concentrations for minimal usage

  • Develop automated washing protocols to reduce variability

• Automated Western Blot Alternatives:

  • Adapt to capillary-based protein separation systems

  • Implement in-cell Western techniques for adherent yeast

  • Utilize automated liquid handlers for all steps

Increasing Throughput:

• Parallel Processing Strategies:

  • Implement magnetic bead-based assays instead of plate-based formats

  • Use filter-bottom plates for simultaneous processing

  • Develop multiplexed detection with differently labeled secondary antibodies

• Readout Acceleration:

  • Switch from colorimetric to fluorescent or chemiluminescent detection

  • Implement homogeneous assay formats (no-wash steps)

  • Use image-based detection for simultaneous assessment of multiple parameters

Quality Control for HTS:

• Robustness Assessment:

  • Calculate Z'-factor to ensure assay quality (aim for >0.5)

  • Include multiple controls on each plate

  • Implement edge-effect controls

• Variability Minimization:

  • Standardize yeast growth and lysis procedures

  • Prepare bulk reagents to minimize batch effects

  • Include internal reference standards

Data Processing Pipeline:

• Automated Analysis:

  • Develop image analysis algorithms for consistent quantification

  • Implement machine learning for phenotype classification

  • Create automated outlier detection systems

• Data Integration:

  • Link antibody-based detection results with:

    • Genetic information (strain backgrounds)

    • Treatment conditions

    • Time-course data

Table 3: High-Throughput Adaptations for YDR061W Antibody Applications

These adaptations would enable researchers to use YDR061W antibody in large-scale studies such as chemical genomics screens or systematic protein interaction mapping projects.